Cargando…

Spontaneous variability of pre-dialysis concentrations of uremic toxins over time in stable hemodialysis patients

BACKGROUND AND AIM: Numerous outcome studies and interventional trials in hemodialysis (HD) patients are based on uremic toxin concentrations determined at one single or a limited number of time points. The reliability of these studies however entirely depends on how representative these cross-secti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eloot, Sunny, Van Biesen, Wim, Roels, Sanne, Delrue, Willem, Schepers, Eva, Dhondt, Annemieke, Vanholder, Raymond, Glorieux, Griet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634633/ https://www.ncbi.nlm.nih.gov/pubmed/29016645 http://dx.doi.org/10.1371/journal.pone.0186010

Ejemplares similares

Does the Adequacy Parameter Kt/V(urea) Reflect Uremic Toxin Concentrations in Hemodialysis Patients?
por: Eloot, Sunny, et al.
Publicado: (2013)

Protein-Bound Uremic Toxin Profiling as a Tool to Optimize Hemodialysis
por: Eloot, Sunny, et al.
Publicado: (2016)

Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis
por: Deltombe, Olivier, et al.
Publicado: (2015)

Uremic Toxin Concentrations are Related to Residual Kidney Function in the Pediatric Hemodialysis Population
por: Snauwaert, Evelien, et al.
Publicado: (2019)

Selective Transport of Protein-Bound Uremic Toxins in Erythrocytes
por: Deltombe, Olivier, et al.
Publicado: (2019)

Response to Tsikas et al. Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149
por: Boelaert, Jente, et al.
Publicado: (2016)

Contribution of the uremic milieu to an increased pro-inflammatory monocytic phenotype in chronic kidney disease
por: Borges Bonan, Natalia, et al.
Publicado: (2019)

Where and When To Inject Low Molecular Weight Heparin in Hemodiafiltration? A Cross Over Randomised Trial
por: Dhondt, Annemieke, et al.
Publicado: (2015)

Assessment of the association between increasing membrane pore size and endotoxin permeability using a novel experimental dialysis simulation set-up
por: Schepers, Eva, et al.
Publicado: (2018)

Protein-bound solute removal during extended multipass versus standard hemodialysis
por: Eloot, Sunny, et al.
Publicado: (2015)

Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC-MS/MS versus ELISA
por: Boelaert, Jente, et al.
Publicado: (2016)

Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update
por: Vanholder, Raymond, et al.
Publicado: (2018)

Gut microbiota dynamics and uraemic toxins: one size does not fit all
por: Joossens, Marie, et al.
Publicado: (2019)

Urinary output and fractional excretion of sodium and urea as indicators of transient versus intrinsic acute kidney injury during early sepsis
por: Vanmassenhove, Jill, et al.
Publicado: (2013)

What If Not All Metabolites from the Uremic Toxin Generating Pathways Are Toxic? A Hypothesis
por: Vanholder, Raymond, et al.
Publicado: (2022)

Carbamoylated Nail Proteins as Assessed by Near-Infrared Analysis Are Associated with Load of Uremic Toxins and Mortality in Hemodialysis Patients
por: De Bruyne, Sander, et al.
Publicado: (2020)

Does P-Cresylglucuronide Have the Same Impact on Mortality as Other Protein-Bound Uremic Toxins?
por: Liabeuf, Sophie, et al.
Publicado: (2013)

Uraemic toxins and cardiovascular disease: in vitro research versus clinical outcome studies
por: Vanholder, Raymond, et al.
Publicado: (2008)

What is new in uremic toxicity?
por: Vanholder, Raymond, et al.
Publicado: (2008)

Influence of severity of illness on neutrophil gelatinase-associated lipocalin performance as a marker of acute kidney injury: a prospective cohort study of patients with sepsis
por: Vanmassenhove, Jill, et al.
Publicado: (2015)

Composite Uremic Load and Physical Performance in Hemodialysis Patients: A Cross-Sectional Study
por: Vanden Wyngaert, Karsten, et al.
Publicado: (2020)

Isolation and Quantification of Uremic Toxin Precursor-Generating Gut Bacteria in Chronic Kidney Disease Patients
por: Gryp, Tessa, et al.
Publicado: (2020)

Association between Protein-Bound Uremic Toxins and Asymptomatic Cardiac Dysfunction in Patients with Chronic Kidney Disease
por: Chinnappa, Shanmugakumar, et al.
Publicado: (2018)

Estimated Glomerular Filtration Rate Is a Poor Predictor of the Concentration of Middle Molecular Weight Uremic Solutes in Chronic Kidney Disease
por: Neirynck, Nathalie, et al.
Publicado: (2012)

Contribution of Hypoalbuminemia and Anemia to the Prognostic Value of Plasma p-Cresyl Sulfate and p-Cresyl Glucuronide for Cardiovascular Outcome in Chronic Kidney Disease
por: Verbeke, Francis, et al.
Publicado: (2022)

Gut Microbiota and Their Derived Metabolites, a Search for Potential Targets to Limit Accumulation of Protein-Bound Uremic Toxins in Chronic Kidney Disease
por: Steenbeke, Mieke, et al.
Publicado: (2021)

Transcriptome Analysis in Patients with Chronic Kidney Disease on Hemodialysis Disclosing a Key Role for CD16(+)CX3CR1(+) Monocytes
por: Schepers, Eva, et al.
Publicado: (2015)

Immunosenescence and Immune Exhaustion Are Associated with Levels of Protein-Bound Uremic Toxins in Patients on Hemodialysis
por: Tourountzis, Theodoros, et al.
Publicado: (2023)

A randomized cross-over study with objective quantification of the performance of an asymmetric triacetate and a polysulfone dialysis membrane using different anticoagulation strategies
por: Vanommeslaeghe, Floris, et al.
Publicado: (2020)

A randomized cross-over study with objective quantification of the performance of an asymmetric triacetate and a polysulfone dialysis membrane using different anticoagulation strategies
por: Vanommeslaeghe, Floris, et al.
Publicado: (2019)

Micro-computed tomography for the quantification of blocked fibers in hemodialyzers
por: Vanommeslaeghe, Floris, et al.
Publicado: (2018)

Chronic Kidney Disease and Fibrosis: The Role of Uremic Retention Solutes
por: Mutsaers, Henricus A. M., et al.
Publicado: (2015)

Association between anticoagulation strategy and quality of life in chronic hemodialysis patients
por: Eloot, Sunny, et al.
Publicado: (2023)

Dietary Fibre Intake Is Associated with Serum Levels of Uraemic Toxins in Children with Chronic Kidney Disease
por: El Amouri, Amina, et al.
Publicado: (2021)

The complexity of sleep disorders in dialysis patients
por: Eloot, Sunny, et al.
Publicado: (2021)

Uraemic toxins and new methods to control their accumulation: game changers for the concept of dialysis adequacy
por: Glorieux, Griet, et al.
Publicado: (2015)

Serum Levels and Removal by Haemodialysis and Haemodiafiltration of Tryptophan-Derived Uremic Toxins in ESKD Patients
por: Paats, Joosep, et al.
Publicado: (2020)

Soluble Tumor Necrosis Factor Receptor 1 and 2 Predict Outcomes in Advanced Chronic Kidney Disease: A Prospective Cohort Study
por: Neirynck, Nathalie, et al.
Publicado: (2015)

Evaluation of Different Dialyzers and the Impact of Predialysis Albumin Priming in Intermittent Hemodialysis With Reduced Anticoagulation
por: Vanommeslaeghe, Floris, et al.
Publicado: (2019)

The optimized anticoagulation strategy in prolonged hemodialysis
por: Thielemans, Raïsa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ijnqkojl4ddhcj0vtgdm2644mr